Ardian Inc., a Menlo Park developer of a medical device to treat congestive heart failure, has raised around $10.08 million to add to its second round of funding, according to a regulatory filing cited by PE Week. WS Investment led the investment, and it was joined by return backers Advanced Technology Ventures, Morgenthaler Ventures and St. Paul Venture Capital.

Separately, we’ve learned the company was incubated at the Foundry, and co-founders are Howard Levin and Mark Gelfand.